Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RENAL TREATMENT CENTERS-SOUTHEAST, LP.

NPI: 1124284500 · CUERO, TX 77954 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/05/2008

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more

$2K
Total Medicaid Paid
6,806
Total Claims
2,311
Beneficiaries
12
Codes Billed
2021-01
First Month
2022-10
Last Month

Provider Details

Authorized OfficialWEY, SAMUEL (VP LICENSURE&CERTIFICATION)
NPI Enumeration Date08/05/2008

Related Entities

Other providers sharing the same authorized official: WEY, SAMUEL

ProviderCityStateTotal Paid
DVA HEALTHCARE RENAL CARE INC NORTH HOLLYWOOD CA $16.47M
DVA HEALTHCARE RENAL CARE INC DELANO CA $16.43M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $15.51M
DVA RENAL HEALTHCARE INC SAN DIEGO CA $14.93M
DVA RENAL HEALTHCARE INC SAN DIEGO CA $13.67M
DVA RENAL HEALTHCARE INC OAKLAND CA $13.42M
DVA RENAL HEALTHCARE INC SAN DIEGO CA $13.25M
DVA HEALTHCARE RENAL CARE INC YUMA AZ $12.88M
DVA HEALTHCARE RENAL CARE INC BAKERSFIELD CA $12.77M
DVA RENAL HEALTHCARE INC FULLERTON CA $12.19M
DVA HEALTHCARE RENAL CARE INC POMONA CA $11.96M
DVA RENAL HEALTHCARE INC ANAHEIM CA $11.32M
DVA RENAL HEALTHCARE INC ESCONDIDO CA $10.94M
DVA HEALTHCARE RENAL CARE INC COSTA MESA CA $10.08M
DVA HEALTHCARE RENAL CARE INC INGLEWOOD CA $9.46M
DVA RENAL HEALTHCARE INC VISALIA CA $9.22M
DVA RENAL HEALTHCARE INC SAN DIEGO CA $8.83M
DVA HEALTHCARE RENAL CARE INC BAKERSFIELD CA $8.56M
DVA HEALTHCARE RENAL CARE INC INGLEWOOD CA $7.78M
DVA RENAL HEALTHCARE INC PALM SPRINGS CA $7.48M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 4,477 $2K
2022 2,329 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90999 Unlisted dialysis procedure, inpatient or outpatient 14 14 $2K
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 4,742 324 $0.00
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 218 175 $0.00
82728 107 106 $0.00
A4657 Syringe, with or without needle, each 337 331 $0.00
83550 110 108 $0.00
85045 310 305 $0.00
83970 169 162 $0.00
82108 43 43 $0.00
85041 323 318 $0.00
85048 323 317 $0.00
83540 110 108 $0.00